{"id":"W2775300375","doi":"10.1016/j.ejca.2017.11.004","title":"Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Veliparib; Medicine; Internal medicine; Gastroenterology; Clinical endpoint; Hazard ratio; PARP inhibitor; Oncology; BRCA mutation; Phases of clinical research; Pancreatic cancer; Confidence interval; Surgery; Cancer; Clinical trial; Breast cancer; Poly ADP ribose polymerase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000912595,0.0001512058,0.0007483539,0.0001738525,0.0001207783,0.00001894007,0.00027262,0.00003700401,0.0002234456],"category_scores_gemma":[0.0004384936,0.0001003119,0.00009921513,0.00009795616,0.0002494265,0.0001486562,0.00006242929,0.0003624087,0.000006325557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001239172,"about_ca_system_score_gemma":0.0005080738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001338983,"about_ca_topic_score_gemma":0.00002458887,"domain_scores_codex":[0.998062,0.0003098653,0.0006809709,0.0001546396,0.0005135132,0.0002790136],"domain_scores_gemma":[0.9979335,0.00004333298,0.0008749242,0.0003513516,0.0005679767,0.0002289132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.13181,0.002193578,0.8498898,0.0000394517,0.0004051517,0.0009993821,0.0005961584,0.000002024642,0.0003015299,0.000003169979,0.0006849286,0.01307486],"study_design_scores_gemma":[0.2252973,0.02258196,0.7503016,0.0004828854,0.0003974032,0.00004530166,0.00002750386,0.00001838832,0.0002296544,0.000002627645,0.0005353632,0.00007999472],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933184,0.000750932,0.000009200243,0.0003845564,0.0001522221,0.0005172803,0.00001290377,0.000005128658,0.004849403],"genre_scores_gemma":[0.9983003,0.0002433401,0.0001887142,0.00003908529,0.0003403986,0.000004217108,0.000006239477,0.00003112853,0.0008465381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09958819,"threshold_uncertainty_score":0.4090599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03449127913236837,"score_gpt":0.3551758726349117,"score_spread":0.3206845935025433,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}